Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.
D000208:Acute Disease; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002496:Central Venous Pressure / Q000187:drug effects; D003498:Cyclic P-Oxides / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D003556:Cystitis / Q000139:chemically induced / Q000473:pathology; D004285:Dogs; D004562:Electrocardiography; D005021:Ethylamines / Q000009:adverse effects; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced; D007275:Injections, Intravenous; D008168:Lung / Q000187:drug effects* / Q000473:pathology; D008297:Male; D009205:Myocarditis / Q000139:chemically induced* / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D010078:Oxazines / Q000009:adverse effects*; D010100:Oxygen / Q000097:blood; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000473:pathology; D012119:Respiration / Q000187:drug effects; D013997:Time Factors; D001743:Urinary Bladder / Q000473:pathology
D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D005021:Ethylamines; D010078:Oxazines; D002245:Carbon Dioxide; D003520:Cyclophosphamide; D010100:Oxygen